AzPA ANNUAL CONVENTION

JUNE 14-17TH | PHOENIX, AZ

THEME: INGREDIENTS FOR SUCCESS!

This four-day annual conference provides over fifteen (15) hours of continuing education, recognition, and networking opportunities for pharmacy professionals of all practice settings.

AzPA Psychiatric Certificate Program

JUNE 14th | PHOENIX, AZ

A practice-based activity designed for pharmacists in all practice settings. The intent of this training program is to provide additional training in the area of psychiatric pharmacy to enhance pharmacists’ clinical knowledge that can be applied directly to the patients they serve.

AzPA Immunization Certificate Program

JUNE 14th | PHOENIX, AZ

This program is an interactive educational program that provides pharmacists and student pharmacists with the skills necessary to become primary sources for vaccine advocacy, education, and administration.

APhA Pharmacist & Patient-Centered Diabetes Care Program

JUNE 14th | PHOENIX, AZ

Gain experience evaluating and adjusting drug therapy regimens for patients with type 1 & type 2 diabetes, counseling patients about lifestyle interventions, analyzing and interpreting self-monitoring of blood glucose results, and assessing the overall health status of patients to identify needed monitoring and interventions.

Pain Management Certificate Program

JULY 28TH | VIRTUAL PROGRAM

Featuring a new kind of Certificate Program! This entire learning experience can be done in the comfort of your own home. It consists of a Home Study Component and a Live Webinar - That's it!

Educate

Learn with us

Advocate

Discover your voice

Connect

Get involved! Serve on a team

RSS AzPA Pharmacy Flash

  • New House bill focuses on Medicare drug price reduction
    ​ The rising costs of drug prices is an issue that many Americans have had to contend with for some time. The out-of-pocket costs that some Americans have to pay for medications can put them in situations where they have to decide between life's necessities or obtaining medications that have the potential to sustain or […]
  • Lilly's baricitinib gets FDA OK, but faces hurdles
    Lilly has been fighting tooth and nail to gain approval for baricitinib for some time. After a three-month delay on its original user fee action date, the FDA issued a Complete Response Letter for the drug in April 2017. At one point, many thought Lilly might abandon the drug altogether.
  • To unlock innovation, pharma needs to be honest about failure
    Many successful leaders agree that a company’s willingness to embrace and learn from failure can unlock innovation – and it’s a lesson the pharmaceutical industry would do well to learn.

Upcoming Events

Upcoming Events